Navigation Links
Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
Date:4/27/2012

e eyes is often an early form of diabetic retinopathy that causes significant vision loss.  Almost all Type 1 diabetics and more than 60% of Type 2 diabetics will develop retinopathy. There is no effective daily drug treatment for diabetic retinopathy other than general measures, such as controlling blood sugar, hypertension, blood lipids, etc. Due to the global diabetes epidemic, diabetic retinopathy is recognized as a high, unmet medical need that would benefit from having oral therapeutic options available. The only treatments available for macular edema now are laser therapy, injection or implantation of drugs into or around the eyeball (not approved in the US or Canada). To our knowledge, Optina™ is the only proposed oral treatment for this condition.

About Optina™
Optina™ is an orally administered ultra low dose of danazol, for the treatment of diabetic macular edema (DME).  Ampio's Chief Scientific Officer discovered an unexpected activity in his investigation of the mechanism of action of danazol: very low doses reversed inflammation-induced increases in the permeability of blood vessels, thus reducing vascular leakage.  Dr. Bar-Or subsequently managed in-vitro studies that suggested this effect may reduce the vasogenic edema produced by various vascular leak syndromes, including diabetic macular edema (DME) which can impair vision and cause blindness. The specific Optina dosages used in the trial are proprietary and subject to multiple patent filings.

Danazol, a derivative of the synthetic steroid ethisterone, was approved by the FDA in the 1970s for endometriosis and, more recently, for other chronic indications, including hereditary angioedema, ITP and fibrocystic disease of the breast.

About Ampio
Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfun
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ampio Strengthens Patent Protection for Lead Drug Ampion™
2. Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule
3. Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results
4. Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
5. Ampio Pharmaceuticals Schedules 2012 Outlook Webcast
6. Executive Changes at Ampio
7. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
8. Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
9. Ampio Responds to Recent Publications by Anonymous Short Sellers
10. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
11. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , and DURHAM, N.C. , ... Inc. today announced its acquisition of assets related to ... PFE ) that had previously been obtained as ... Sciences also acquired all of Pfizer,s rights to the ... Icagen brand and will provide comprehensive services for ion ...
(Date:7/2/2015)... China , 2. Juli 2015 ... für DNA-Screening in Hongkong vom American College ... in Hongkong ist das erste klinische Next-Generation-Sequencing ... ein CAP-Zertifkat erhält und somit die ... zu den bestehenden US FDA - 21 ...
(Date:7/2/2015)... SEOUL , South Korea, July 2, 2015 ... of a new E-CUBE Series ultrasound system. Developed to ... of clinical areas, the E-CUBE 15 EX produces superb ... outstanding clinical performance in women,s health, general imaging, and ... The latest in the renowned E-CUBE Series, ...
Breaking Medicine Technology:Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3
... Trial to be Presented at Retrovirus ConferenceLEXINGTON, Mass., Feb. ... ) announced today that a National Institutes of Health ... PRO 2000, the Company,s candidate vaginal microbicide for HIV ... HIV infection than women who received a placebo or ...
... Europe Represents New Treatment Approach for Serious Chronic ... AMGN ) today announced that the ... Nplate(R) (romiplostim) for the treatment of splenectomised adult ... are refractory to other treatments (e.g. corticosteroids, immunoglobulins). ...
Cached Medicine Technology:Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 2Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 3Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 4Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 5Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 6Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 2Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 3Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 4Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 5Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 6Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 7Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 8
(Date:7/2/2015)... ... ... LIFX ” was featured on NewsWatch as part of its monthly Tech Report, which ... expert and special reporter for NewsWatch, conducted the review and shared with viewers how ... According to the U.S. Department of Energy, it’s very important to use energy-efficient light ...
(Date:7/2/2015)... ... ... Global leader and compression innovator, SIGVARIS North America, is proud ... style that’s quick on its feet, men will love this fun new way to ... because a simple change in socks can dramatically help improve overall leg health by ...
(Date:7/2/2015)... Diego, CA (PRWEB) , ... July 02, 2015 , ... ... and a passion for social fitness. Built to function as a lifestyle community, Active ... giving them the opportunity to network, meet, and participate in discussions or group events. ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... Divakar R. Krishnareddy, M.D., to the orthopedic and spine surgery team at their ... sprains, strains, bursitis, and tendonitis. Along with the spine and spine surgery, Dr. ...
(Date:7/2/2015)... ... , ... Real Time Pain Relief (RTPR), makers of the popular rub-on pain relief ... to sponsor The Fifth Annual Big Sky Professional Bull Riders Event being held this ... their popular pain relief lotion and products at the family friendly event that features two ...
Breaking Medicine News(10 mins):Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 2Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 3
... authors suggest , FRIDAY, Jan. 29 (HealthDay News) -- Bees ... think the faces are odd-shaped flowers, a new study reports. ... France determined that bees could be trained to recognize face-like ... doing so. , However, this doesn,t mean that bees can ...
... may have taken counterfeit Viagra, study says , FRIDAY, ... over the Internet, especially drugs purporting to treat erectile dysfunction, ... contends. , At best the drugs won,t help you and ... , "You may be wasting your money or you may ...
... ... to Interactive Agency for Website Support , ... St. Louis, MO (PRWEB) January 29, 2010 -- The Net Impact , ... Karla Smith Foundation (KSF), an organization focused on working to provide support to family and ...
... ... Stys, MD with Sanford Heart Hospital was recently selected as case of the week by ... community. , ... (Vocus) January 28, 2009 -- A unique procedure performed by Tom Stys, MD ...
... ... dehydration and the spread of water-borne diseases from contaminated water, DynGlobal deploys its DG ... solar-powered water filtration and purification units will be installed throughout the nation as permanent ... ...
... ... and wine pairings from Laura,s Lean Beef. Your sweetheart,s heart will thank you. ... Lexington, KY (PRWEB) ... most inventive of holidays. With its emphasis on sweets, it’s not the healthiest either. ...
Cached Medicine News:Health News:Fake Drugs Bought on the Web Pose Big Health Risks 2Health News:Fake Drugs Bought on the Web Pose Big Health Risks 3Health News:The Net Impact is Proud to Announce Partnership with the Karla Smith Foundation 2Health News:The Net Impact is Proud to Announce Partnership with the Karla Smith Foundation 3Health News:The Net Impact is Proud to Announce Partnership with the Karla Smith Foundation 4Health News:Sanford Heart Hospital Physicians Again Recognized Internationally for Innovative Techniques 2Health News:Sanford Heart Hospital Physicians Again Recognized Internationally for Innovative Techniques 3Health News:DynGlobal and Project Hope Partner to Bring Permanent Clean Water Solutions to Devastated Haiti 2Health News:DynGlobal and Project Hope Partner to Bring Permanent Clean Water Solutions to Devastated Haiti 3Health News:Win Over Their Heart in More Ways than One this Valentine's Day with a Romantic, Heart-Healthy Meal 2Health News:Win Over Their Heart in More Ways than One this Valentine's Day with a Romantic, Heart-Healthy Meal 3Health News:Win Over Their Heart in More Ways than One this Valentine's Day with a Romantic, Heart-Healthy Meal 4
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
This fixed-volume digital micropipet is used to accurately measure and transfer 50 microliters of solution....
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... pipette is ideal for repeated ... Fixed volume FInnpipettes offer the ... other Finnpipette Digital pipettes: ... (1-40ul), Soft-touch tip ejection, Safety ...
Medicine Products: